MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41416-022-02061-5

Медицинская библиотека · British journal of cancer · 2022

Dual [68Ga]DOTATATE and [18F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score.

Chan David L, Hayes Aimee R, Karfis Ioannis, Conner Alice, Furtado O'Mahony Luke, Mileva Magdalena, Bernard Elizabeth, Roach Paul, Marin Gwennaëlle, Pavlakis Nick, Schembri Geoffrey, Gnanasegaran Gopinath, Marin Clementine, Vanderlinden Bruno, Navalkissoor Shaunak, Caplin Martyn E, Flamen Patrick, Toumpanakis Christos, Bailey Dale L

Многоцентровое исследованиеСтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Gastroenteropancreatic neuroendocrine neoplasms (GEPNENs) are heterogeneous in clinical course, biology, and outcomes. The NETPET score predicts survival by scoring uptake on dual [68Ga]DOTATATE and [18F]FDG PET/CT scans. We aimed to validate previous single-centre findings in a multicentre, international study.

METHODS

Dual scans were assigned a NETPET score of P1 (DOTATATE positive/FDG negative), P2-4 (DOTATATE positive/FDG positive), or P5 (DOTATATE negative/FDG positive). NETPET score, histological grade, age at diagnosis, and presence/absence of extrahepatic disease were compared to overall survival/time to progression on univariate and multivariate analysis.

RESULTS

319 metastatic/unresectable GEPNEN patients were included. The NETPET score was significantly associated with overall survival and time to progression on univariate and multivariate analysis (all p < 0.01). Median overall survival/time to progression was 101.8/25.5 months for P1, 46.5/16.7 months for P2-4, and 11.5/6.6 months for P5. Histological grade correlated with overall survival and time to progression on univariate and multivariate analysis (all p < 0.01), while presence/absence of extrahepatic disease did not. Age at diagnosis correlated with overall survival on univariate and multivariate analysis (p < 0.01). The NETPET score also correlated with histological grade (p < 0.001).

CONCLUSION

This study validates the NETPET score as a prognostic biomarker in metastatic GEPNENs, capturing the complexity of dual PET imaging.

Для цитирования: Chan David L, Hayes Aimee R, Karfis Ioannis, Conner Alice, Furtado O'Mahony Luke, Mileva Magdalena, Bernard Elizabeth, Roach Paul, Marin Gwennaëlle, Pavlakis Nick, Schembri Geoffrey, Gnanasegaran Gopinath, Marin Clementine, Vanderlinden Bruno, Navalkissoor Shaunak, Caplin Martyn E, Flamen Patrick, Toumpanakis Christos, Bailey Dale L. Dual [68Ga]DOTATATE and [18F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score.. British journal of cancer. 2022. DOI: 10.1038/s41416-022-02061-5.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.